DOI:
10.1055/s-00034917
Kinder- und Jugendmedizin
LinksClose Window
References
Burgos-Vargas R, Casasola-Vargas J, Gutierrez-Suarez R.
A 3-month double-blind placebo-controlled randomized trial of infliximab in juvenile-onset spondyloarthritis (SpA) and a 52-week open extension.
Clin Exp Rheumatol 2008;
26: 745
We do not assume any responsibility for the contents of the web pages of other providers.